The POSEIDON Regimen: IMFINZI(r) (durvalumab) + IMJUDO(r) (tremelimumab-actl) and Platinum-Based Chemotherapy. The First and Only Finite-Coursea Anti-CTLA-4 in a Dual Immunotherapy + Platinum-Based Chemotherapyb Regimen for mNSCLC
Durvalumab;Imfinzi;Imjudo;Tremelimumab-actl
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: The POSEIDON Regimen: IMFINZI(r) (durvalumab) + IMJUDO(r) (tremelimumab-actl) and Platinum-Based Chemotherapy. The First and Only Finite-Coursea Anti-CTLA-4 in a Dual Immunotherapy + Platinum-Based Chemotherapyb Regimen for mNSCLC ### Output: Durvalumab;Imfinzi;Imjudo;Tremelimumab-actl